DoseCraft
VapeHeatLab
Gushlatti 07202023 L2 Lab Sample
About
Gushlatti 07202023 L2 Lab Sample is a hybrid cannabis strain. Lab samples test between 10.6% and 14.3% THC, with caryophyllene (0.35%) as the dominant terpene.
Why does Gushlatti 07202023 L2 Lab Sample feel pain-relieving?
Gushlatti 07202023 L2 Lab Sample's pain-relieving effects are linked to its dominant caryophyllene (0.35%), one of the few terpenes that binds directly to CB2 cannabinoid receptors. Complemented by humulene (0.13%), associated with appetite suppression and anti-inflammatory effects.
Strain Profile
May Help With
Caryophyllene has strong anti-inflammatory properties
Caryophyllene binds to CB2 receptors for pain relief
Linalool has calming, stress-relieving properties
Linalool is known for anti-anxiety effects
Based on terpene research and reported effects. Not medical advice. Consult a healthcare professional for medical decisions.
Similar Strains
Strains with a similar profile you might enjoy
Quick Info
- Type
- hybrid
- Breeder
- Not verified
- THC
- 10.6–14.3%
- Chemotype
- Caryophyllene-dominant
What is Caryophyllene?
Spicy, peppery terpene found in black pepper, cloves, and cinnamon.
Learn more →
← Back to all strainsAbout Gushlatti 07202023 L2 Lab Sample
- Gushlatti 07202023 L2 Lab Sample is a hybrid cannabis strain. Hybrids combine characteristics of both indica and sativa genetics.
- Gushlatti 07202023 L2 Lab Sample typically tests at 10.6% to 14.3% THC. This is a moderate-potency strain suitable for a wide range of users.
- The dominant terpenes in Gushlatti 07202023 L2 Lab Sample are Caryophyllene, Humulene, Linalool. Terpenes influence the aroma, flavor, and effects of a cannabis strain.